Neurocrine Biosciences
NBIX
#1368
Rank
C$21.44 B
Marketcap
C$215.09
Share price
0.79%
Change (1 day)
19.65%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of September 2025 : C$4.15 Billion

According to Neurocrine Biosciences 's latest financial reports the company has C$4.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$3.71 B25.53%
2023-12-31$C$2.96 B27.75%
2022-12-31$C$2.31 B32.34%
2021-12-31$C$1.75 B21.94%
2020-12-31$C$1.43 B72.63%
2019-12-31$C$0.83 B27.02%
2018-12-31$C$0.65 B39.97%
2017-12-31$C$0.46 B10.57%
2016-12-31$C$0.42 B-28.13%
2015-12-31$C$0.58 B143.11%
2014-12-31$C$0.24 B88.95%
2013-12-31$C$0.12 B-16.5%
2012-12-31$C$0.15 B151.18%
2011-12-31$C$61.11 M216.04%
2010-12-31$C$19.33 M364.79%
2009-12-31$C$4.16 M-90.7%
2008-12-31$C$44.71 M-62.24%
2007-12-31$C$0.11 B-67.68%
2006-12-31$C$0.36 B-19.32%
2005-12-31$C$0.45 B-3.98%
2004-12-31$C$0.47 B-6.77%
2003-12-31$C$0.50 B43.25%
2002-12-31$C$0.35 B-28.37%
2001-12-31$C$0.49 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Repligen
RGEN
C$2.88 B-30.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
C$13.31 B 220.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
-C$8.84 Million-100.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$33.00 B 694.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-C$3.6 Billion-186.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.82 B 2,999.48%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.69 B-83.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$50.37 Million-101.21%๐Ÿ‡บ๐Ÿ‡ธ USA